William Blair analyst Andy Hsieh initiates coverage on POINT Biopharma Global (NASDAQ:PNT) with a Outperform rating.
The Latest Analyst Ratings for Ascendis Pharma
Over the past 3 months, 13 analysts have published their opinion on Ascendis Pharma (NASDAQ:ASND) stock. These analysts…